FIELD: biotechnology.
SUBSTANCE: invention relates to a compound of formula 1
that is a new rebamipide prodrug, and to the pharmaceutical composition thereof.
EFFECT: new rebamipide prodrug with absorption rate 25 times higher than that of rebamipide, which can be used for prevention or treatment of gastric ulcer, acute gastritis, chronic gastritis, xerophthalmia, cancer, osteoarthritis, rheumatoid arthritis, or obesity.
7 cl, 3 tbl, 204 ex, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| DERIVATIVE OF PYRIDONE CARBOXYLIC ACID OR ITS SALT | 1996 |
|
RU2177945C1 |
| GLUCOKINASE ACTIVATORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AS ACTIVE INGREDIENT | 2008 |
|
RU2450001C2 |
| DERIVATIVES OF 9-AMINOACRIDINE AND METHOD FOR THEIR PREPARING | 2002 |
|
RU2269524C2 |
| CARBAMOYLOXYARYL ALKANOYL ARYLPIPERAZINE COMPOUND, PHARMACEUTICAL COMPOSITIONS CONTAINING SAID COMPOUND AND METHOD OF TREATING PAIN, ANXIETY AND DEPRESSION | 2008 |
|
RU2460731C2 |
| TIENOPYRIMYDINE [3,2-D] PRODUCTION, WHICH HAS INHIBITORY ACTIVITY AGAINST PROTEIN KINASES | 2012 |
|
RU2625799C2 |
| ORAL PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF "DRY EYE" SYNDROME CONTAINING REBAMIPID OR ITS PRECURSOR | 2014 |
|
RU2632107C2 |
| DERIVATIVES OF QUINOLINE- OR NAPHTHYRIDINE CARBOXYLIC ACID AND METHODS OF THEIR SYNTHESIS | 1995 |
|
RU2120940C1 |
| NEW HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF | 2016 |
|
RU2675375C1 |
| NOVEL FUSED PYRIMIDINE DERIVATIVES FOR INHIBITION OF TYROSINE KINASE ACTIVITY | 2011 |
|
RU2585177C2 |
| NITROGEN-CONTAINING AROMATIC DERIVATIVES, PHARMACEUTICAL COMPOSITION CONTAINING THEREOF, METHOD FOR TREATMENT AND USING | 2003 |
|
RU2310651C2 |
